s6y

425 Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Filed
Accession number
0001213900-26-111424

Documents

  1. CURRENT REPORT 425
  2. AMENDMENT NO. 1 TO THE AMENDED AND RESTATED DEFINITIVE MERGER AGREEMENT, DATED OCTOBER 13, 2026, BETWEEN DRUGS MADE IN AMERICA ACQUISITION CORP. AND POWER ANALYTICS GLOBAL CORP EX-2.1

On sec.gov